메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Spielwarenmesse honours outstanding innovations with the ToyAward

NUREMBERG, Germany, Jan. 28, 2026 -- An innovative game concept, the highest quality of workmanship and attractive market potential – all these criteria are combined in the six outstanding product ideas that were honoured with the prestigious ToyAward on the second day of Spielwarenmesse. In the Baby & Infant category, Tonies won with My First Tonies. In PreSchool, the game Der Berg ruft by Auzou jeux/Hutter Trade came out on top, while Franckh-Kosmos took the lead in the SchoolKids category, with Temple Twist. In the Teenager & Adults category, iDventure claimed the winner's
- 김장윤(JASON KIM) 기자
- 2026-01-28 22:46
High-Trend International Group (NASDAQ: HTCO) Appoints Mr. Chew Men Leong, the Former Chief of Navy of the Republic of Singapore Navy, as a Director to Strengthen Its Global Maritime Strategy and Cross-Border Capital Capabilities

NEW YORK, Jan. 28, 2026 -- High-Trend International Group (NASDAQ: HTCO) ("HTCO" or the "Company"), a global ocean transportation company, today announced the appointment of Mr. Chew Men Leong, former Chief of Navy of the Republic of Singapore Navy and a veteran leader in infrastructure and global business, as a director of the Company, effective as of January 26, 2026. This appointment marks a pivotal step in HTCO's strategy to deepen its global maritime footprint, strengthen its capital position and enhance its presence in the Singapore market. Core Leaders
- 황정호 기자
- 2026-01-28 22:00
REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools

BELTSVILLE, Md., Jan. 29, 2026 -- REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system licensed from Profluent (Emeryville, CA, USA). StemEdit encompasses REPROCELL's proprietary clinical gene-editing technology and its new gene-edited iPSC lines that are ready for immediate use. These offerings combine REPROCELL's StemRNA™ Clinical iPSC Seed Clones, with OpenCRISPR-1™ enabled engineering workflows, ensuring a GMP-aligned, traceable, a
- 김갑성 기자
- 2026-01-28 22:00
UnionPay Enables 25 International Wallets to Support Weixin Pay QR Code in China' Mainland

SHANGHAI, Jan. 28, 2026 -- When Thai tourist Naree visited Shanghai, she paid easily for coffee at a neighborhood café by scanning a Weixin Pay QR code using the same K PLUS mobile wallet as she used at home, because her mobile wallet was linked to her Thai UnionPay card. Now international visitors from 11 countries and regions travelling to China's mainland can enjoy the same seamless mobile payment experience just as Naree. The collaboration between UnionPay International and Weixin Pay (also known as WeChat) now supports 25 UnionPay-partnered international wallets. Users only
- 황정호 기자
- 2026-01-28 21:55
NYSE Content Advisory: Pre-Market Update + First Lady Melania Trump to Ring NYSE Bell for Doc 'Melania'

NEW YORK, Jan. 28, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + First Lady Melania Trump to Ring NYSE Bell for Doc 'Melania' Kristen Scholer delivers the pre-market update on January 28th First Lady Melania Trump will ring the Opening Bell at the New York Stock Exchange this morning ahead of the release of Amazon MGM Studios Film, Melania. The film offers access,
- 김장윤(JASON KIM) 기자
- 2026-01-28 21:55
Scienjoy Integrates AI Capabilities into Live Streaming Platforms Across Markets

BEIJING, Jan. 28, 2026 -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive entertainment leader in the Chinese market, today announced the deployment of AI-powered live streamers across its domestic and overseas platforms. This milestone marks a critical transition from technology development to large-scale commercial deployment, with innovative products—ranging from streamer avatars modeled on real individuals to fully digital streamers—being rolled out across multiple platforms. Streamer Avatars Launched in C
- 김장윤(JASON KIM) 기자
- 2026-01-28 21:30
YY Group Repurchases Outstanding Warrants from Holders

Redemption Strengthens the Company's Capital Structure SINGAPORE, Jan. 28, 2026 -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced that it has reached an agreement with certain warrant holders to redeem all outstanding warrants issued as part of a registered direct offering completed on September 11, 2025. Under the terms of the agreement, the Company will repurchase and cancel warrants exercisable for up to 14,285,718 Class A o
- 황정호 기자
- 2026-01-28 21:30
Global Appeal 2026: Education as the Key to Ending Leprosy Stigma and Discrimination

[ 메디채널 김갑성 기자 ] — Launch Event in Brussels Will Be Live-Streamed Worldwide — TOKYO, Jan. 28, 2026 -- The transformative power of education in replacing fear with knowledge and prejudice with empathy lies at the heart of the Global Appeal 2026 to End Stigma and Discrimination against Persons Affected by Leprosy. The appeal will be launched at a ceremony in Brussels, Belgium, on Thursday, 29 January 2026. The event is being co-hosted by Education International and the Sasakawa Leprosy (Hansen's Disease) Initiative, in partnership with the Damien Foundation. Since
- 김갑성 기자
- 2026-01-28 21:00
SwiftStart Confirms Strategic Investment Intent in TIRX, Beginning with $80 Million at $1.50 per Share

BEIJING, Jan. 28, 2026 -- TIRX (Nasdaq: TIRX) (the "Company" or "TIRX") today announced that it has entered into a strategic Memorandum of Understanding ("MOU") with its strategic investor, SwiftStart Inc. Pursuant to the MOU, SwiftStart Inc. has expressed its intention to pursue an initial equity investment in TIRX at a proposed purchase price of US$1.50 per share, with a proposed total investment amount of US$80 million. The execution of the MOU marks a further step in the advancement and evaluation of the strategic cooperation between TIRX and SwiftStar
- 황정호 기자
- 2026-01-28 20:15
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating

Ranked in the top one percent among more than 150,000 companies assessed globally Recognized for strengthened sustainability management across all four assessment categories INCHEON, South Korea, Jan. 28, 2026 -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it has received the EcoVadis' Platinum Sustainability Rating, the highest level of recognition for corporate sustainability performance. The Platinum rating places Samsung Biologics in the top one percent of companies eval
- 김갑성 기자
- 2026-01-28 20:00

이전

91 92 93 94 95 96 97 98 99 100

많이 본 기사

최근기사

2026-03-03_TUE

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 03시 40분